Covid 19: A Multicenter, Adaptive, Randomized Controlled Platform Trial of the Safety and Efficacy of Antithrombotic Strategies in Hospitalized Adults with COVID-19 (ACTIV-4)

Pharmacology, Toxicology and Pharmaceutical Science

1. Anticoagulant Agent 100%
2. Cytokine 100%
3. Protein S 50%
4. Thrombosis 50%
5. Arterial Thromboembolism 50%
6. Viral Respiratory Tract Infection 50%
7. Blood Stasis 50%
8. Asymptomatic Infection 50%
9. Thromboplastin 50%
10. Inflammation 50%
11. Multiple Organ Failure 50%
12. Hypertensive Factor 50%
13. Virus Infection 50%
14. Procoagulant 50%
15. Acute Disease 50%
16. Respiratory Tract Disease 50%
17. Thrombin 50%
18. Pandemic 50%
19. Anticoagulant Protein 50%
20. Venous Thromboembolism 50%
21. Respiratory Failure 50%
22. SARS Coronavirus 50%
23. Respiratory Tract 50%
24. Protein C 50%
25. Diseases 50%
26. Pathogenesis 50%
27. Influenza 50%